CTO · Accelerate Diagnostics, Inc (AXDX)

Larry Mertz

A named executive officer of Accelerate Diagnostics in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$952,163

Salary $335,939Stock awards $616,224

FY2022: $466,574

3rd of 3 named executive officers at Accelerate Diagnostics by FY2023 total.

3 named officers on file for Accelerate Diagnostics, FY2023

Larry Mertz’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Accelerate Diagnostics’s whole pay program stands against its peers

  • Accelerate Diagnostics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AXDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 11, 2024 (DEF 14A).

Free

Get Larry Mertz’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Larry Mertz compensation by year

Accelerate Diagnostics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Accelerate Diagnostics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$329,231$335,939
Bonus$0$0
Stock awards$137,343$616,224
Option awards$0$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$466,574$952,163

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Accelerate Diagnostics, Inc DEF 14A filed April 11, 2024, accession 0001104659-24-046295, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Accelerate Diagnostics, Inc filed document, accession 0001104659-24-046295. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2024.

$467K
$952K
FY22
FY23
SalaryStock awards

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU66,353$260,104—
RSU7,164$28,083—
RSU1,000$3,920—
RSU283$1,109—
Option3,334—$70.90

Per the Outstanding Equity Awards at Fiscal Year-End table in Accelerate Diagnostics, Inc's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Accelerate Diagnostics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Jack PhillipsPresident and CEO$3,004,105
David PatienceCFO$1,156,704
Larry Mertz · this pageCTO$952,163

The full Accelerate Diagnostics compensation record

free company brief

This page is one person within Accelerate Diagnostics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Accelerate Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Larry Mertz's compensation dossier · One-time report. No refunds.